No definition available.
Viral encephalitis, not elsewhere classified/unspecified, including avohilmo
AB1_VIRAL_ENCEPHALITIS_NOS_WIDE
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
873 |
4. Check minimum number of eventsNone |
873 |
5. Include endpointsNone |
873 |
6. Filter based on genotype QC (FinnGen only) |
780 |
Control definitions (FinnGen only)
- Control exclude
- AB1_VIRAL_CNS
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Viral encephalitis, not elsewhere classified/unspecified, including avohilmo
based on the number of shared cases.
Similar with more cases:
- Viral infections of the central nervous system, including avohilmo
- Certain infectious and parasitic diseases, including avohilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 780 | 406 | 374 |
| Unadjusted period prevalence (%) | 0.16 | 0.14 | 0.17 |
| Median age at first event (years) | 57.50 | 54.66 | 60.57 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 806
- Matched controls
- 8060
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A86
ICD-10 Finland
Unspecified viral encephalitis
+∞
307.7
741
*
TAB00
NOMESCO Finland
Lumbar puncture
18.9
263.7
233
170
N03AX14
ATC
levetiracetam; systemic
13.7
111.1
109
91
AA1AD
NOMESCO Finland
CT of head and brain
4.7
103.2
433
1610
XA800
NOMESCO Finland
Neuropsychological investigation
9.8
101.8
128
153
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
6.6
101.6
192
364
R41.0
ICD-10 Finland
Disorientation, unspecified
10.8
96.7
111
117
R56.8
ICD-10 Finland
Other and unspecified convulsions
8.3
94.8
137
194
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
8.1
91.8
136
198
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
11.3
89.4
99
99
A87.9
ICD-10 Finland
Viral meningitis, unspecified
+∞
76.3
72
*
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
11.7
68.8
73
68
G40.9
ICD-10 Finland
Epilepsy, unspecified
8.4
68.4
94
124
G04.9
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis, unspecified
179.4
64.0
66
*
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
11.3
59.3
64
61
F05.9
ICD-10 Finland
Delirium, unspecified
10.2
57.6
67
71
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.4
53.8
254
949
N03AF02
ATC
oxcarbazepine; oral
7.6
51.2
76
109
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.2
50.6
158
445
N03AX18
ATC
lacosamide; systemic
21.5
49.0
37
18
A85.8
ICD-10 Finland
Other specified viral encephalitis
+∞
47.4
45
*
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
10.1
47.3
55
58
Z2445
NOMESCO Finland
Psychologist
5.9
43.6
83
154
G05.1*B00.4
ICD-10 Finland
Herpesviral meningoencephalitis
+∞
43.1
41
*
R50.9
ICD-10 Finland
Fever, unspecified
3.2
41.4
200
745
5AB01, ,
NOMESCO Finland
95.3
41.2
45
5
XF400
NOMESCO Finland
ECG with 12 standard connections
3.1
38.1
195
748
N03AG01
ATC
valproic acid; systemic, rectal
4.2
32.8
95
250
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.8
32.1
202
860
R4120
NOMESCO Finland
Occupational therapy
3.9
30.6
97
272
R51.80
ICD-10 Finland
Headache
2.8
29.4
186
791
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.4
28.6
283
1486
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.0
28.4
141
525
183
Kela drug reimbursment
Lamotrigin and topiramate
11.1
27.9
30
28
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.1
27.4
127
454
XA400
NOMESCO Finland
EEG
28.1
26.0
35
13
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
7.2
25.2
38
55
WX730
NOMESCO Finland
Conventional respirator
9.4
24.9
30
33
WX892
NOMESCO Finland
Monitored bed care
3.3
24.7
100
329
ZX120
NOMESCO Finland
Intravenous
3.1
24.5
115
413
G03.9
ICD-10 Finland
Meningitis, unspecified
50.0
24.4
29
6
G41.9
ICD-10 Finland
Status epilepticus, unspecified
29.2
23.3
31
11
B94.1
ICD-10 Finland
Sequelae of viral encephalitis
+∞
23.0
22
*
N71
ICPC
Meningitis/encephalitis
236.4
22.7
23
*
A41.9
ICD-10 Finland
Sepsis, unspecified
4.6
22.5
55
126
A84.8
ICD-10 Finland
Other tick-borne viral encephalitis
+∞
22.0
21
*
N03AB02
ATC
phenytoin; systemic
7.0
20.9
32
47
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
20.6
427
2897
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
8.2
20.1
27
34
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
19.4
216
1162
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
17.3
19.3
30
18
A84.9
ICD-10 Finland
Tick-borne viral encephalitis, unspecified
+∞
18.8
18
*
G05.1*A85.0
ICD-10 Finland
Encephalitis, myelitis or encephalomyelitis (in) enteroviral
+∞
17.8
17
*
B00.4
ICD-10 Finland
Herpesviral encephalitis
173.4
16.6
17
*
R11
ICD-10 Finland
Nausea and vomiting
2.6
16.3
99
406
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.3
16.1
132
622
TKC20
NOMESCO Finland
Catheterisation of bladder
2.9
16.0
79
290
N05BA09
ATC
clobazam; oral
16.4
15.3
24
15
R4150
NOMESCO Finland
Neuropsychological rehabilitation
11.6
14.9
27
24
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.7
14.8
86
344
G05.1
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis in viral diseases classified elsewhere
+∞
14.6
14
*
G04.8
ICD-10 Finland
Other encephalitis, myelitis and encephalomyelitis
+∞
14.6
14
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.4
14.6
111
505
Z3231
NOMESCO Finland
Registered nurse
1.9
14.4
238
1455
N03AF01
ATC
carbamazepine; oral, rectal
3.2
14.2
59
196
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.1
13.9
148
773
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.6
13.9
47
137
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.1
13.7
148
778
G01*A69.2
ICD-10 Finland
Meningitis (in) Lyme disease
142.3
13.5
14
*
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
4.5
13.4
33
76
G41.0
ICD-10 Finland
Grand mal status epilepticus
40.8
13.2
16
*
N28
ICPC
Limited function/disability (N)
5.3
13.0
26
50
N29
ICPC
Neurological sympt/complt other
4.8
12.9
29
62
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
4.9
12.7
28
59
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.6
12.7
75
303
N05BA01
ATC
diazepam; systemic, rectal
2.2
12.5
119
594
N03AX16
ATC
[U] pregabalin
1.9
12.4
193
1149
A28
ICPC
Limited function/disability NOS
2.0
12.4
164
926
R53
ICD-10 Finland
Malaise and fatigue
1.8
12.3
228
1434
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
9.2
12.3
25
28
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
5.2
12.3
25
49
J05AB11
ATC
valaciclovir; oral
2.1
12.3
136
720
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
6.1
12.2
21
35
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.9
12.1
167
955
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.8
12.1
64
244
Z3226
NOMESCO Finland
Physiotherapist
2.0
12.0
157
882
R42
ICD-10 Finland
Dizziness and giddiness
1.9
11.8
196
1189
N05AH04
ATC
quetiapine; oral
1.9
11.8
161
917
H02AB06
ATC
prednisolone; systemic
1.7
11.8
384
2825
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
5.4
11.6
23
44
R47.0
ICD-10 Finland
Dysphasia and aphasia
8.8
11.6
24
28
R4110
NOMESCO Finland
Physiotherapy
1.8
11.6
232
1491
G09
ICD-10 Finland
Sequelae of inflammatory diseases of central nervous system
+∞
11.5
11
*
G02.0*B00.3
ICD-10 Finland
Herpesviral meningitis
121.7
11.5
12
*
E86
ICD-10 Finland
Volume depletion
3.9
11.4
34
91
N03AX09
ATC
lamotrigine; oral
2.9
11.3
53
189
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.1
11.3
113
575
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
3.3
11.2
43
136
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.2
11.1
102
502
Z2221
NOMESCO Finland
Medical doctor
1.8
11.0
222
1426
F05.8
ICD-10 Finland
Other delirium
9.8
10.8
21
22
L28
ICPC
Limited function/disability (L)
1.9
10.8
162
950
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
18.1
10.8
16
9
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.3
10.5
80
364
F07.1
ICD-10 Finland
Postencephalitic syndrome
+∞
10.4
10
*
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
3.1
10.4
44
148
C03CA01
ATC
furosemide; systemic
1.7
10.4
252
1700
N30.0
ICD-10 Finland
Acute cystitis
1.9
10.4
142
807
N03AE01
ATC
clonazepam; systemic
2.8
10.3
54
205
R25.1
ICD-10 Finland
Tremor, unspecified
3.7
10.3
33
93
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.2
10.2
85
402
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.0
10.1
120
649
N05CF01
ATC
zopiclone; oral
1.7
10.0
258
1765
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
10.0
282
1976
F02.89*G40.9
ICD-10 Finland
Dementia in epilepsy
40.6
10.0
12
*
ZXD05
NOMESCO Finland
Urgent procedure
1.7
9.9
243
1642
Z2446
NOMESCO Finland
Social worker
2.5
9.9
66
283
B02.0
ICD-10 Finland
Zoster encephalitis
55.7
9.7
11
*
A87.8
ICD-10 Finland
Other viral meningitis
+∞
9.4
9
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.6
9.3
346
2584
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.5
9.2
56
230
N06AX11
ATC
mirtazapine; oral
1.6
9.1
274
1941
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
4.5
9.1
22
50
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.4
9.1
66
294
R4130
NOMESCO Finland
Speech therapy
3.4
9.0
32
97
N05AX08
ATC
risperidone; systemic
2.1
8.9
87
437
G40
ICD-10 Finland
Epilepsy
8.1
8.9
19
24
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
8.8
226
1537
N05BA04
ATC
oxazepam; oral
1.7
8.8
214
1436
N05AA02
ATC
levomepromazine; systemic
2.9
8.7
40
142
5CM18, ,
NOMESCO Finland
11.7
8.6
15
13
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.4
8.6
31
95
J01MA02
ATC
ciprofloxacin; systemic
1.6
8.5
299
2192
N06AB04
ATC
citalopram; systemic
1.7
8.5
166
1049
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
4.4
8.4
21
49
J01DB01
ATC
cefalexin; oral
1.7
8.4
649
5694
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.8
8.4
150
924
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.7
8.3
26
72
A02BC02
ATC
pantoprazole; systemic
1.6
8.3
525
4379
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
4.3
8.2
21
50
R1260
NOMESCO Finland
Evaluation of communicative skills
4.0
8.2
23
59
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
2.9
8.2
39
141
N99
ICPC
Neurological disease other
6.9
8.1
19
28
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
6.4
8.0
20
32
JN4BD
NOMESCO Finland
Extensive body CT
2.0
8.0
85
442
N06AX16
ATC
venlafaxine; oral
1.9
7.9
116
671
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
7.9
279
2041
J01MA12
ATC
levofloxacin; systemic
1.7
7.8
148
925
B34.9
ICD-10 Finland
Viral infection, unspecified
3.1
7.8
32
106
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.1
7.8
79
403
SPAT1254
SPAT
Administration of medicine
1.8
7.7
122
723
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.7
7.7
42
163
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.3
7.7
57
256
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.0
7.6
79
407
C07AB07
ATC
bisoprolol; oral
1.5
7.6
371
2906
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.4
7.5
51
221
H02AB07
ATC
prednisone; oral
1.8
7.5
108
623
F10.49
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without information about seizures
13.5
7.4
12
9
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
11.0
7.3
13
12
H02AB09
ATC
hydrocortisone; systemic
3.4
7.3
26
79
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.1
7.2
65
317
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
7.2
255
1859
G41.2
ICD-10 Finland
Complex partial status epilepticus
30.3
7.2
9
*
F03
ICD-10 Finland
Unspecified dementia
2.6
7.1
41
164
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
7.1
173
1154
ZXY02
NOMESCO Finland
Neuropsychologist
10.1
7.0
13
13
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
2.7
7.0
36
136
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.8
7.0
114
682
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.9
6.9
92
516
N06AX21
ATC
duloxetine; oral
1.9
6.9
94
532
WW200
NOMESCO Finland
Immunization
3.3
6.9
25
77
WX882
NOMESCO Finland
High dependency care
3.0
6.9
29
98
R55
ICD-10 Finland
Syncope and collapse
1.9
6.8
93
526
G40.89
ICD-10 Finland
Other epilepsy
11.1
6.8
12
11
EBA15
NOMESCO Finland
Extraction of multiple teeth
2.6
6.8
37
144
A04
ICPC
Weakness/tiredness general
1.7
6.8
127
790
TK800
NOMESCO Finland
Hemodialysis
3.6
6.8
22
63
N03AX12
ATC
[U] gabapentin; oral
1.7
6.7
125
777
6BA02, ,
NOMESCO Finland
22.7
6.7
9
*
H02AB04
ATC
methylprednisolone; systemic
1.8
6.7
112
675
N06AB10
ATC
escitalopram; oral
1.6
6.7
157
1037
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.7
6.6
34
128
N03AX11
ATC
topiramate; oral
3.2
6.6
26
84
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
6.0
6.6
17
29
N05AH03
ATC
olanzapine; systemic
2.2
6.5
56
268
A06AD11
ATC
lactulose; oral
1.7
6.5
116
711
WX002
NOMESCO Finland
Sedation and analgesia
1.7
6.5
143
928
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
6.4
88
498
G05.1*B02.0
ICD-10 Finland
Zoster encephalitis
70.4
6.4
7
*
H3603, E103,
ICD-10 Finland
8.2
6.3
13
16
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
5.6
6.3
17
31
L01BA01
ATC
methotrexate; systemic
2.9
6.3
29
103
G05.1*B01.1
ICD-10 Finland
Varicella encephalitis
+∞
6.3
6
*
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
2.0
6.1
68
359
A10AB05
ATC
insulin aspart; parenteral
2.0
6.1
66
345
F43.1
ICD-10 Finland
Post-traumatic stress disorder
2.9
6.1
27
94
N03AX23
ATC
brivaracetam; systemic
12.6
6.1
10
8
G93.4
ICD-10 Finland
Encephalopathy, unspecified
12.6
6.1
10
8
A02BC01
ATC
omeprazole; systemic
1.5
6.1
207
1488
RD210, ,
NOMESCO Finland
3.6
6.1
19
53
SPAT1255
SPAT
Intravenous administration of medicine
2.1
6.0
54
263
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
285
171
25.24
307.65
1.6
1.4
714.56
456.51
mg/l
8.71
276
164
190
35
70.72
307.65
1.3
1.1
—
—
—
0
0
284
151
28.50
307.65
1.5
1.4
3.82
3.73
mmol/l
0.33
268
143
233
67
48.51
307.65
1.3
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
170
36
59.58
298.51
1.3
1.1
—
—
—
0
0
231
150
21.19
278.09
1.8
1.5
511.15
879.66
e6/l
0.20
198
115
229
148
21.22
276.24
1.7
1.4
49.44
10.84
e6/l
3.88
190
106
141
28
60.82
249.81
1.3
1.2
—
—
—
0
0
129
27
56.69
225.66
1.4
1.4
—
—
—
0
0
141
51
33.30
213.37
1.2
1.0
—
—
—
0
0
100
15
75.97
185.10
1.2
1.1
—
—
—
0
0
95
17
63.22
170.47
1.3
1.1
—
—
—
0
0
95
17
63.22
170.47
1.3
1.1
—
—
—
0
0
86
17
56.51
151.13
1.4
1.1
—
—
—
0
0
85
23
41.20
138.86
1.2
1.1
—
—
—
0
0
219
443
6.41
108.96
2.6
2.5
22.76
21.35
au/ml
0.05
15
46
203
404
6.38
102.28
1.5
1.3
62.84
47.25
au/ml
—
9
33
100
86
13.13
99.85
1.3
1.1
—
—
—
0
0
93
76
13.70
95.72
1.6
2.0
—
—
—
0
0
54
10
57.81
95.44
1.4
1.2
—
—
—
0
0
47
11
45.31
78.88
1.2
1.0
—
—
—
0
0
120
183
7.53
77.29
1.3
1.1
—
4.51
—
0
24
115
173
7.59
74.92
1.8
3.2
27.73
33.44
umol/l
1.41
96
158
64
69
9.99
54.30
1.6
2.1
—
—
—
0
0
61
9
73.10
53.97
1.4
1.2
—
—
—
0
0
43
26
17.41
51.65
1.2
1.0
—
—
—
0
0
48
42
12.09
46.86
1.3
1.0
—
—
—
0
0
48
47
10.80
43.47
1.2
1.2
—
—
—
0
0
47
47
10.56
41.93
1.6
1.1
63.01
45.93
mg/l
0.76
42
37
47
8
62.25
40.71
1.3
1.1
—
—
—
0
0
45
6
79.46
40.33
1.3
1.2
—
—
—
0
0
44
6
77.24
39.32
1.3
1.2
—
—
—
0
0
92
205
4.94
39.30
1.3
1.3
—
—
—
0
0
398
2188
2.62
39.06
3.4
2.1
222.76
269.27
u/l
0.35
382
2086
266
1241
2.71
35.89
2.3
1.9
—
—
—
0
0
37
37
10.43
32.92
1.6
1.2
0.54
0.50
ratio
0.66
24
19
240
1108
2.66
32.62
2.4
2.1
29.68
29.48
s
0.21
232
1077
35
33
11.04
32.41
1.5
1.0
2.15
1.13
u/l
0.54
17
20
210
936
2.68
30.37
2.2
1.8
—
—
—
0
0
33
32
10.71
29.96
1.3
1.0
1704.52
1556.16
miu/ml
0.23
33
32
195
887
2.58
26.70
2.3
1.9
—
—
—
0
0
30
7
44.38
24.72
1.3
1.0
—
—
—
0
0
30
8
38.88
24.08
1.3
1.0
—
—
—
0
0
563
4105
2.23
23.80
7.7
5.3
6.94
6.67
mmol/l
1.83
543
3887
470
3230
2.09
22.70
16.2
15.2
1.25
1.26
inr
0.20
402
2692
229
1196
2.28
22.61
4.0
3.5
0.80
0.82
mmol/l
2.03
212
1133
168
771
2.49
22.21
4.5
4.1
5.87
5.76
kpa
0.80
162
747
33
47
7.28
22.19
1.6
2.0
241.29
193.76
e6/l
0.55
28
38
194
952
2.37
22.10
8.6
6.4
1.01
1.05
mmol/l
1.17
180
883
496
3499
2.09
22.05
10.4
7.6
1.21
1.21
mmol/l
0.39
438
3025
138
579
2.67
21.95
4.5
2.8
9.61
10.77
g/l
2.52
130
538
32
48
6.90
20.53
1.7
2.0
613.11
561.22
e6/l
0.18
27
36
160
744
2.44
20.43
4.7
4.2
1.70
1.77
mmol/l
0.08
141
631
507
3681
2.02
19.88
7.4
6.7
10.57
11.79
umol/l
2.60
486
3516
590
4526
2.13
19.87
6.8
4.7
4676.45
2078.61
e6/l
0.23
11
76
441
3068
1.97
19.36
6.6
5.3
34.39
35.72
g/l
4.97
418
2901
144
654
2.46
19.28
4.3
3.5
4.82
4.52
kpa
0.80
139
631
142
641
2.48
19.26
9.9
7.8
8.27
9.92
mmol/l
2.69
133
614
289
1751
2.01
18.82
5.5
4.2
88.11
88.94
%
0.22
278
1725
75
247
3.25
18.37
2.2
1.8
—
—
—
0
0
22
5
45.12
18.31
1.4
1.0
—
—
—
0
0
446
3162
1.92
18.00
10.1
6.9
1.21
1.21
mmol/l
0.57
422
2922
314
1984
1.95
17.93
4.2
3.3
0.32
0.41
e6/l
0.63
245
1432
266
1598
1.99
17.51
3.1
2.7
4.25
5.79
e6/l
1.29
244
1452
527
3980
1.94
17.21
12.1
9.9
4.42
4.12
e9/l
2.03
466
3465
27
43
6.46
16.37
3.0
2.1
—
—
—
0
0
44
109
4.21
16.33
4.8
6.1
367.50
371.49
umol/l
0.06
38
98
61
193
3.34
15.93
1.6
1.6
—
—
—
0
0
56
169
3.49
15.74
1.5
1.5
—
—
—
0
0
21
8
26.89
15.65
1.8
1.3
—
—
—
0
0
343
2308
1.85
15.58
4.6
3.4
29.13
75.08
e6/l
0.89
275
1745
124
578
2.35
15.49
3.6
2.9
65.72
66.77
g/l
0.70
109
538
67
237
2.99
14.52
2.6
1.5
0.22
0.24
g/l
0.55
61
229
103
456
2.44
14.40
1.8
1.7
—
—
—
0
0
201
1174
1.95
13.88
1.8
1.7
1129.56
1180.22
nmol/l
0.33
157
889
67
245
2.89
13.68
2.6
1.5
1.12
1.19
g/l
1.01
62
235
47
139
3.53
13.62
1.5
1.4
—
—
—
0
0
47
139
3.53
13.62
1.5
1.4
—
—
—
0
0
630
5219
1.95
13.61
10.8
8.3
77.32
80.16
u/l
0.97
606
4948
320
2189
1.77
13.18
3.1
2.6
56.54
97.93
u/l
0.59
296
2042
378
2716
1.74
13.06
5.7
3.9
28.01
66.37
ng/l
1.13
286
1930
24
44
5.59
12.65
1.0
1.0
42.01
37.26
ng/l
0.16
16
29
24
44
5.59
12.65
1.0
1.0
628.14
622.23
ng/l
0.02
14
31
24
44
5.59
12.65
1.0
1.0
328.94
281.50
ng/l
0.25
16
30
66
251
2.77
12.54
2.1
3.0
—
—
—
0
0
367
2638
1.72
12.49
5.4
4.0
48.70
101.65
e6/l
1.67
284
1836
151
833
2.00
12.16
7.8
8.5
0.47
0.86
mmol/l
0.46
129
690
110
540
2.20
12.04
1.9
1.7
—
—
—
0
0
54
188
3.01
12.04
1.6
1.6
—
—
—
0
0
311
2159
1.72
11.85
3.3
3.3
1317.66
1384.12
ng/l
0.14
261
1847
334
2369
1.70
11.73
3.8
3.6
2.33
2.35
mmol/l
2.65
292
2163
42
129
3.38
11.50
1.2
1.1
—
16.60
—
0
40
150
847
1.95
11.23
7.7
8.4
12.12
12.15
kpa
0.02
142
818
150
847
1.95
11.23
7.7
8.4
5.05
5.09
kpa
0.16
142
815
199
1234
1.81
11.12
3.8
3.0
1.47
1.05
e6/l
0.99
111
636
87
400
2.32
11.12
1.7
1.5
—
—
—
0
0
31
79
4.04
11.11
1.3
1.2
—
—
—
0
0
131
709
2.01
11.07
2.3
2.0
382.54
383.04
nmol/l
0.01
125
662
44
145
3.15
10.77
1.8
1.5
—
—
—
0
0
14
5
28.45
10.75
1.1
1.0
—
—
—
0
0
124
671
2.00
10.46
3.2
2.5
29.55
32.13
u/l
0.40
102
575
329
2383
1.64
10.30
3.7
3.4
32.97
32.82
u/l
0.02
311
2263
142
822
1.88
9.79
4.7
4.3
229.97
256.92
u/l
1.38
133
774
51
195
2.72
9.61
1.6
1.6
—
—
—
0
0
89
448
2.11
9.10
4.5
4.0
1.87
1.73
mmol/l
0.14
64
340
14
9
15.80
9.05
1.8
1.3
—
—
—
0
0
554
4653
1.61
8.74
4.3
3.4
52.69
48.41
u/l
0.54
524
4391
37
125
3.05
8.72
1.5
1.8
—
—
—
0
0
167
1055
1.74
8.54
3.3
2.6
20.58
22.72
%
1.57
148
990
22
53
4.24
8.50
1.3
1.6
—
—
—
0
0
394
3075
1.55
8.48
2.4
2.1
92.22
95.33
pmol/l
0.69
228
1634
265
1892
1.60
8.41
2.2
2.3
2.77
2.91
mg/l
0.49
224
1634
176
1134
1.71
8.37
3.3
2.6
2.25
2.29
g/l
0.30
157
1051
30
94
3.28
8.01
1.5
1.6
—
—
—
0
0
456
3706
1.53
7.95
5.4
3.9
9.61
6.36
estimate
0.12
112
788
459
3738
1.53
7.91
5.5
3.9
0.00
0.42
estimate
0.51
100
731
97
530
1.94
7.90
4.7
3.9
5.18
5.12
kpa
0.23
90
514
452
3671
1.53
7.87
5.4
3.9
0.00
0.00
estimate
0.50
109
771
174
1151
1.65
7.41
4.1
3.2
3.83
2.16
e6/l
0.72
87
554
61
287
2.22
7.40
2.2
1.9
0.90
2.59
ug/l
0.92
51
253
78
404
2.03
7.39
5.1
3.3
0.67
0.61
%
0.84
78
404
38
144
2.72
7.32
1.4
1.5
—
—
—
0
0
7
0
+∞
7.30
1.3
0.0
—
—
—
0
0
66
324
2.13
7.21
1.5
2.0
1.64
1.49
g/l
0.61
55
293
28
90
3.19
7.19
9.6
8.1
8.02
6.97
mmol/l
0.75
23
74
584
5061
1.56
7.18
6.1
4.3
13.97
11.81
mm/h
2.43
553
4728
47
202
2.41
7.02
1.4
1.2
24.33
2.65
u/ml
—
6
20
132
824
1.72
6.96
2.9
2.9
9.66
8.15
umol/l
0.28
113
739
47
203
2.40
6.95
1.4
1.3
9.71
9.93
u/ml
—
9
35
114
683
1.78
6.94
2.3
2.5
0.22
0.21
g/l
0.76
106
637
179
1212
1.61
6.90
3.3
2.6
11.48
12.95
umol/l
2.34
160
1131
32
115
2.86
6.81
1.3
1.5
—
—
—
0
0
40
163
2.53
6.70
1.4
1.2
48.00
51.62
u/ml
—
5
17
197
1378
1.57
6.59
4.6
4.0
104.17
326.59
ng/l
2.89
155
1066
242
1773
1.52
6.56
3.7
2.9
349.26
347.87
umol/l
0.07
218
1561
60
298
2.09
6.37
1.9
2.3
32.73
39.54
u/l
2.00
51
267
27
93
2.97
6.21
1.7
1.5
—
—
—
0
0
35
139
2.59
6.19
1.6
1.5
—
—
—
0
0
42
185
2.34
5.97
1.8
2.5
12.49
12.10
mg/l
0.08
37
171
17
45
3.84
5.83
1.2
1.6
—
—
—
0
0
57
288
2.05
5.80
3.9
2.0
6.93
6.77
iu/ml
0.02
14
69
191
1365
1.52
5.72
3.1
3.0
2.45
2.45
mmol/l
0.09
164
1238
229
1710
1.47
5.52
3.1
2.4
—
—
—
0
0
38
167
2.34
5.45
1.9
1.5
—
—
—
0
0
204
1494
1.49
5.40
2.0
1.4
2.18
2.44
g/l
1.35
134
930
53
268
2.05
5.40
2.0
1.9
—
—
—
0
0
47
230
2.11
5.22
1.7
1.4
0.03
0.09
iu/ml
—
6
42
43
204
2.17
5.17
4.5
3.7
3.64
2.79
ratio
0.27
30
122
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
44
211
2.15
5.15
2.8
2.7
0.42
0.35
iu/ml
0.45
23
109
15
40
3.80
5.11
1.3
1.6
—
—
—
0
0
19
60
3.22
5.06
1.3
1.1
—
—
—
0
0
21
71
3.01
5.01
1.5
1.5
59.73
56.37
%
0.15
15
51
71
407
1.82
5.01
2.6
3.5
4.31
4.58
pmol/l
1.43
63
363
265
2066
1.42
4.99
1.9
1.7
20.22
20.42
nmol/l
0.07
228
1747
19
61
3.17
4.94
1.2
1.1
—
—
—
0
0
19
61
3.17
4.94
1.2
1.1
—
—
—
0
0
18
58
3.15
4.66
1.2
1.1
—
—
—
0
0
39
186
2.15
4.65
3.4
3.0
1.84
1.59
mmol/l
0.68
39
179
87
542
1.68
4.61
4.9
4.2
89.30
83.71
ng/l
0.21
71
485
128
877
1.55
4.59
1.8
1.8
1.70
1.47
%
1.54
108
765
31
135
2.35
4.57
1.3
1.4
122.15
159.78
au/ml
1.05
13
43
258
2032
1.40
4.50
4.9
3.3
0.00
0.06
estimate
0.77
93
617
45
230
2.01
4.49
4.9
3.8
31.07
41.14
mg/l
0.46
36
195
45
230
2.01
4.49
4.9
3.8
60.79
77.05
mg/l
0.21
36
195
19
66
2.92
4.35
1.5
1.7
—
—
—
0
0
19
66
2.92
4.35
1.5
1.7
—
—
—
0
0
19
66
2.92
4.35
1.2
1.1
—
—
—
0
0
19
66
2.92
4.35
1.5
1.7
—
—
—
0
0
45
233
1.99
4.34
1.6
1.3
—
—
—
0
0
211
1615
1.42
4.32
2.0
1.7
0.95
1.36
mg/l
2.17
165
1256
20
72
2.82
4.31
1.3
1.2
—
—
—
0
0
37
179
2.12
4.27
1.7
1.7
—
—
—
0
0
46
243
1.95
4.20
3.3
2.5
9.88
10.63
g/l
0.45
39
220
18
64
2.85
3.98
4.3
3.5
12.69
12.96
index
0.06
13
45
366
3096
1.33
3.92
3.0
2.5
77.33
76.60
nmol/l
0.19
333
2777
13
32
4.11
3.91
1.8
2.1
2.33
1.83
umol/l
1.16
13
25
36
179
2.06
3.90
3.1
2.2
129.75
127.91
g/l
0.17
28
148
87
567
1.60
3.88
2.9
2.5
4.50
7.35
ug/l
1.84
73
509
335
2803
1.33
3.84
5.6
3.8
0.03
0.03
estimate
0.01
93
647
14
38
3.73
3.81
1.3
1.6
—
—
—
0
0
42
223
1.93
3.80
1.3
1.4
—
—
—
0
0
378
3223
1.33
3.79
3.5
2.8
—
—
estimate
—
0
0
35
175
2.05
3.74
1.6
1.5
16269.78
10761.86
e6/l
0.46
27
124
16
56
2.89
3.64
1.1
1.4
1.15
1.25
promille
0.08
11
43
186
1431
1.39
3.64
1.7
1.7
429.85
27792210.40
pmol/l
1.42
159
1191
129
930
1.46
3.62
2.3
2.5
181.65
119.11
ug/g
0.61
111
745
13
35
3.76
3.60
1.4
1.8
—
—
—
0
0
13
35
3.76
3.60
1.4
1.8
—
—
—
0
0
13
35
3.76
3.60
1.4
1.8
—
—
—
0
0
13
35
3.76
3.60
1.4
1.8
—
—
—
0
0
21
86
2.48
3.57
1.4
1.3
—
—
—
0
0
82
538
1.58
3.57
9.2
3.8
1.22
1.23
mmol/l
0.46
75
465
31
152
2.08
3.50
1.3
1.3
368.70
259.46
u/ml
0.54
23
81
6
6
10.06
3.50
1.0
3.5
—
—
—
0
0
18
69
2.65
3.49
3.0
3.0
—
—
—
0
0
385
3318
1.31
3.47
3.5
3.1
121.76
122.54
ug/l
0.03
353
3107
34
176
1.97
3.33
1.1
1.2
—
—
—
0
0
250
2041
1.33
3.30
5.6
4.0
0.00
0.01
estimate
1.34
99
718
35
184
1.94
3.29
4.6
3.2
2.61
1.96
index
0.40
23
104
48
283
1.74
3.16
3.3
2.4
4.22
4.19
g/l
0.07
41
261
48
283
1.74
3.16
3.3
2.4
7.44
7.30
g/l
0.21
41
261
48
283
1.74
3.16
3.3
2.4
4.05
3.73
g/l
0.31
41
261
480
4291
1.29
3.16
3.4
3.2
—
—
—
0
0
36
194
1.90
3.16
1.4
1.3
—
—
—
0
0
708
6709
1.45
3.05
31.0
16.2
26.02
24.62
mg/l
0.57
655
5537
13
45
2.92
3.03
4.3
3.5
0.77
0.91
index
0.44
13
45
5
5
10.05
2.98
3.0
6.0
—
—
—
0
0
42
245
1.75
2.89
3.0
2.3
97.55
90.86
%
1.13
42
238
44
713
0.60
2.88
1.6
2.0
3.81
3.51
ratio
0.51
31
572
38
216
1.80
2.85
1.2
1.4
313.63
294.93
ug/g
0.20
19
131
9
230
0.38
2.71
1.2
1.1
1.45
1.53
g/l
—
9
230
15
60
2.53
2.71
1.1
1.0
—
—
—
0
0
284
2417
1.27
2.64
4.3
3.4
7.29
7.74
mmol/l
0.97
253
2062
29
156
1.89
2.60
3.9
3.1
7.94
7.65
mmol/l
0.18
29
150
160
1267
1.33
2.56
1.3
1.3
29.72
32.07
iu/ml
0.10
47
380
12
42
2.88
2.55
1.4
2.4
—
—
—
0
0
23
116
2.01
2.47
1.2
1.2
7.69
5.46
u/ml
0.26
13
54
201
1651
1.29
2.46
6.0
4.1
1.02
1.02
kg/l
0.43
141
1106
41
251
1.67
2.41
3.9
2.7
1.76
1.13
g/l
0.33
33
223
97
718
1.40
2.38
5.0
3.4
—
—
—
0
0
7
17
4.14
2.36
2.0
2.4
29.69
18.08
umol/l
—
7
17
11
39
2.85
2.35
1.3
1.1
—
—
—
0
0
43
269
1.63
2.34
3.5
2.5
3.16
2.98
g/l
0.39
36
247
38
231
1.68
2.30
7.9
4.5
1.53
1.49
mg/l
0.12
38
206
8
23
3.50
2.27
1.1
1.2
—
—
—
0
0
32
522
0.60
2.19
1.4
1.7
3.92
3.46
mmol/l
0.90
20
386
36
220
1.67
2.16
3.7
2.5
0.00
0.02
g/l
0.50
31
200
40
252
1.62
2.14
1.5
1.3
—
—
—
0
0
560
5216
1.24
2.12
5.0
4.3
14.90
14.80
pmol/l
0.41
520
4770
12
49
2.47
2.11
1.2
1.7
—
—
—
0
0
9
31
2.92
2.07
2.1
3.0
—
63344.71
—
0
7
145
1167
1.30
2.06
1.3
1.3
9.51
10.18
u/ml
0.04
56
449
35
216
1.65
2.03
3.8
2.6
0.00
0.00
g/l
-0.00
30
188
263
2275
1.23
2.03
4.7
4.2
9.16
9.37
mg/mmol
0.03
177
1441
8
26
3.10
2.01
1.6
2.0
—
—
—
0
0
8
26
3.10
2.01
1.6
2.0
—
—
—
0
0
16
77
2.10
1.97
3.1
4.1
—
—
—
0
0
24
134
1.82
1.97
4.8
3.2
0.86
0.88
nmol/l
0.06
18
112
52
356
1.49
1.96
1.1
1.0
—
—
—
0
0
14
64
2.21
1.95
5.2
2.6
741.07
823.09
mg
0.12
14
64
197
1658
1.25
1.94
1.4
1.3
2.64
1.36
u/ml
0.33
46
457
5
11
4.57
1.94
1.0
1.0
—
—
—
0
0
8
27
2.98
1.94
2.4
2.0
—
—
—
0
0
11
239
0.45
1.91
1.6
1.1
0.77
0.90
g/l
1.04
11
239
7
22
3.20
1.88
6.1
3.8
11.34
10.22
kpa
—
7
22
7
22
3.20
1.88
6.1
3.8
5.35
4.73
kpa
—
7
22
707
6799
1.32
1.87
33.6
19.1
138.98
139.64
mmol/l
7.61
697
6669
6
17
3.55
1.84
1.2
1.1
—
—
—
0
0
5
12
4.19
1.82
1.4
1.3
—
—
—
0
0
707
6805
1.32
1.81
33.5
19.3
3.96
3.98
mmol/l
0.72
695
6658
17
87
1.97
1.81
3.5
2.7
1.19
1.19
mmol/l
0.01
17
87
9
36
2.52
1.74
3.0
2.3
—
—
—
0
0
8
30
2.68
1.72
1.0
1.1
—
—
—
0
0
17
89
1.93
1.71
1.4
1.6
—
—
—
0
0
17
89
1.93
1.71
3.5
2.6
4.08
4.03
mmol/l
0.20
17
89
17
89
1.93
1.71
3.5
2.6
106.53
105.37
mmol/l
0.52
17
89
17
89
1.93
1.71
1.4
1.6
—
—
—
0
0
650
6204
1.25
1.70
6.1
5.3
1.82
1.90
mu/l
1.03
604
5740
48
334
1.46
1.70
2.1
1.5
0.44
0.32
mg/l
0.46
22
149
12
55
2.20
1.68
1.3
1.3
—
79.50
—
0
6
6
19
3.17
1.66
1.2
1.1
—
—
—
0
0
17
90
1.91
1.66
1.4
1.5
—
—
—
0
0
15
76
1.99
1.65
1.5
2.8
27.50
19.95
mg/l
—
6
32
5
14
3.59
1.61
2.8
1.1
1.05
1.24
mmol/l
—
5
8
20
114
1.77
1.57
1.3
1.3
12.00
4.43
u/ml
—
6
42
17
92
1.87
1.57
1.3
1.5
—
—
—
0
0
12
57
2.12
1.55
1.6
2.1
15.10
21.29
nmol/l
2.29
12
52
154
1293
1.24
1.55
1.5
1.6
—
—
—
0
0
19
108
1.78
1.51
1.0
1.1
—
—
—
0
0
6
21
2.87
1.51
2.8
1.4
—
—
—
0
0
37
251
1.50
1.50
2.1
2.3
146.79
3929.93
u/l
—
10
103
251
2818
0.84
1.49
2.1
2.0
1.42
1.35
mmol/l
0.74
207
2381
21
124
1.71
1.48
5.9
3.2
9.15
9.31
pmol/l
0.03
21
124
17
94
1.83
1.48
1.4
1.5
—
—
—
0
0
17
94
1.83
1.48
1.4
1.5
—
—
—
0
0
9
39
2.32
1.43
1.2
1.1
—
—
—
0
0
68
521
1.33
1.42
2.8
2.6
74.97
67.26
ml/min/173m2
0.66
29
226
101
818
1.27
1.40
4.7
4.8
31.68
32.05
%
0.11
68
540
642
6656
0.83
1.37
5.9
5.7
2.57
2.69
mmol/l
2.64
588
6195
9
41
2.21
1.37
1.2
1.4
—
—
—
0
0
9
41
2.21
1.37
1.2
1.4
—
—
—
0
0
33
226
1.48
1.31
1.3
1.3
10.12
9.26
u/l
0.10
27
176
9
176
0.51
1.29
1.4
1.5
—
—
—
0
0
629
6524
0.84
1.28
5.1
4.9
1.36
1.45
mmol/l
5.97
571
6063
8
35
2.30
1.27
1.3
1.4
—
—
—
0
0
8
35
2.30
1.27
1.3
1.4
—
—
—
0
0
28
188
1.51
1.23
1.9
1.8
2.77
4.74
iu/l
—
9
72
5
19
2.64
1.21
1.0
1.0
—
—
—
0
0
93
762
1.25
1.19
12.5
7.0
—
—
—
0
0
25
168
1.50
1.11
2.0
2.4
63.78
89.86
ug/min
0.20
14
102
635
6559
0.85
1.09
5.2
5.1
4.44
4.58
mmol/l
2.54
581
6129
22
144
1.54
1.09
1.0
1.2
0.12
2.33
u/ml
2.33
14
79
11
59
1.88
1.07
2.5
1.7
2.60
2.41
u/field
—
5
32
30
214
1.42
1.01
1.3
1.2
—
—
—
0
0
30
214
1.42
1.01
1.2
1.2
—
—
—
0
0
35
258
1.37
0.98
1.5
1.7
—
—
—
0
0
657
6370
1.17
0.97
25.3
15.5
82.43
81.66
ml/min/173m2
0.37
630
5877
7
36
1.95
0.97
1.0
1.3
18.71
9.47
mm/h
—
7
36
19
125
1.53
0.94
1.6
1.7
—
—
—
0
0
10
55
1.83
0.92
1.4
1.3
—
—
—
0
0
10
55
1.83
0.92
1.4
1.3
—
—
—
0
0
19
126
1.52
0.92
1.1
1.1
11.32
3.78
u/ml
0.73
12
73
15
94
1.61
0.91
1.1
1.2
—
—
—
0
0
8
42
1.91
0.88
1.6
1.5
—
1020533.17
iu/ml
—
0
6
12
72
1.68
0.85
1.2
1.2
—
—
titre
—
0
0
15
97
1.56
0.81
1.1
1.1
—
—
—
0
0
31
233
1.34
0.80
1.2
1.3
200.60
251.28
miu/ml
0.32
15
114
0
26
0.00
0.78
0.0
1.2
—
8.71
—
0
26
85
989
0.84
0.77
1.5
1.5
—
—
—
0
0
6
34
1.77
0.76
9.7
3.4
0.75
0.85
%
—
6
34
9
53
1.71
0.75
1.0
1.2
113.44
101.15
pmol/l
—
9
53
14
204
0.68
0.69
1.1
1.5
—
—
—
0
0
7
44
1.60
0.65
1.9
1.5
—
—
—
0
0
48
396
1.23
0.64
1.8
2.0
—
—
—
0
0
10
63
1.59
0.62
1.3
1.2
3173.00
322831.59
e6/l
—
5
44
32
254
1.27
0.60
1.6
1.6
11.79
9.32
u/ml
—
8
56
63
540
1.18
0.59
1.5
1.4
—
—
—
0
0
8
53
1.51
0.58
1.7
1.7
12.35
12.49
umol/l
—
8
48
719
7081
1.14
0.54
34.9
20.8
81.86
78.17
umol/l
1.00
714
6995
6
38
1.58
0.54
1.3
1.9
174.33
108.64
ng/l
—
6
38
9
134
0.67
0.52
2.0
1.8
—
—
—
0
0
17
126
1.36
0.52
1.1
1.1
0.61
2.20
u/ml
—
10
66
6
41
1.47
0.50
1.2
2.0
—
—
—
0
0
6
41
1.47
0.50
1.2
2.0
—
—
—
0
0
37
308
1.21
0.49
1.4
1.4
24.52
22.92
iu/l
0.10
29
253
7
48
1.46
0.47
1.3
1.3
—
—
—
0
0
8
117
0.68
0.46
1.4
1.5
45.90
53.25
ug/l
—
8
117
31
257
1.21
0.43
1.7
2.0
42.90
38.81
nmol/l
0.40
31
243
553
5656
0.93
0.42
34.3
20.8
332.18
332.57
g/l
0.40
547
5624
8
60
1.34
0.40
2.0
1.5
—
—
—
0
0
615
6257
0.93
0.38
4.4
4.2
1.39
1.28
mmol/l
2.34
555
5774
9
67
1.35
0.38
6.3
2.1
13.06
13.04
%
—
9
67
9
68
1.33
0.37
3.0
1.6
—
—
—
0
0
13
98
1.33
0.37
1.0
1.1
—
2.27
—
0
19
712
7039
1.10
0.35
17.2
11.9
26.33
26.51
u/l
0.11
694
6855
12
155
0.77
0.33
1.6
1.6
—
—
—
0
0
91
843
1.09
0.30
2.4
2.2
—
—
—
0
0
83
770
1.09
0.27
2.2
2.1
—
—
—
0
0
127
1344
0.93
0.27
3.8
3.2
0.71
0.76
ug/l
0.35
90
845
725
7306
0.92
0.25
41.3
24.6
132.36
135.48
g/l
6.90
719
7232
9
75
1.20
0.25
2.0
3.2
4.07
5.60
nmol/l
—
9
75
52
475
1.10
0.24
1.9
2.1
—
—
—
0
0
77
718
1.08
0.23
3.4
4.4
4.21
26.86
ug/l
1.30
66
605
725
7303
0.93
0.23
41.9
25.0
39.46
40.43
%
5.07
718
7224
725
7303
0.93
0.23
40.9
24.4
4.43
4.50
e12/l
3.90
713
7152
5
38
1.32
0.23
2.6
1.9
27.20
29.21
umol/l
—
5
33
5
40
1.25
0.22
1.2
1.3
41.20
16.85
u/l
—
5
34
725
7301
0.93
0.22
40.9
24.4
90.79
90.95
fl
0.40
718
7228
0
11
0.00
0.21
0.0
1.0
—
0.06
—
0
5
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
0.60
—
0
10
0
12
0.00
0.21
0.0
1.0
—
0.01
—
0
6
0
12
0.00
0.21
0.0
1.0
—
2.60
—
0
6
725
7299
0.93
0.21
41.0
24.5
253.80
248.67
e9/l
1.13
715
7165
6
49
1.23
0.20
1.5
1.5
—
22.25
—
0
8
176
1824
0.96
0.19
4.3
4.5
21.77
21.60
%
0.04
83
843
12
99
1.22
0.19
4.5
1.9
33.83
33.00
pg
0.29
12
99
39
357
1.10
0.18
1.3
1.3
—
—
—
0
0
14
164
0.85
0.18
1.3
1.3
—
—
—
0
0
50
465
1.08
0.17
1.2
1.2
78.27
146.50
u/ml
1.47
16
181
620
6255
0.96
0.16
7.4
6.3
41.24
39.23
mmol/mol
4.74
577
5883
20
220
0.91
0.12
1.5
1.5
—
—
—
0
0
21
192
1.10
0.11
1.6
1.4
—
—
—
0
0
5
44
1.14
0.10
1.2
1.4
—
24.00
—
0
5
5
46
1.09
0.09
1.2
1.5
—
322.00
—
0
5
5
48
1.04
0.09
1.0
1.1
—
—
—
0
0
637
6401
0.98
0.08
5.5
5.0
6.14
5.94
mmol/l
2.65
571
5873
9
88
1.02
0.07
1.4
1.6
—
—
—
0
0
28
295
0.95
0.06
3.6
3.5
865.39
4841.16
u/ml
0.62
23
258
226
2273
0.99
0.02
5.3
5.4
2.51
2.85
ug/l
0.24
209
2046
12
114
1.05
0.00
1.2
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
48.67
—
0
6
0
6
0.00
0.00
0.0
1.2
—
10.67
—
0
6
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
9
0.00
-0.00
0.0
3.4
—
76.44
—
0
9
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: AB1_VIRAL_ENCEPHALITIS_NOS_WIDE – Viral encephalitis, not elsewhere classified/unspecified, including avohilmo
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).